23andMe’s failure shows how risky it can be to invest in a SPAC - MarketWatch
1. 23andMe is headed towards bankruptcy, revealing SPAC risks. 2. Post-merger, 23andMe has seen significant cash depletion. 3. Its revenue dropped from $55 million to $44 million year-over-year. 4. SPAC mergers often attract high-risk, early-stage companies. 5. Overall, 40 companies have declared bankruptcy post-SPAC listings.